Dimension Therapeutics, Inc. Deferred Offering Costs
Dimension Therapeutics, Inc. had Deferred Offering Costs of $206.00 thousand as of 2017-09-30, per its 10-Q filed 2017-11-06.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2017-11-06
- 2017-09-30: Deferred Offering Costs $206.00K.
- 2017-06-30: Deferred Offering Costs $205.00K.
- 2017-03-31: Deferred Offering Costs $205.00K.
- 2016-12-31: Deferred Offering Costs $145.00K.
| Period end | Deferred Offering Costs |
|---|---|
| 2017-09-30 | $206.00K 10-Q · filed 2017-11-06 |
| 2017-06-30 | $205.00K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $205.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $145.00K 10-Q · filed 2017-11-06 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-09 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-24 |